<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">20352</article-id><article-id pub-id-type="doi">10.7554/eLife.20352</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Computational and Systems Biology</subject></subj-group></article-categories><title-group><article-title>Computationally designed high specificity inhibitors delineate the roles of BCL2 family proteins in cancer</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-64123"><name><surname>Berger</surname><given-names>Stephanie</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3738-5907</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-5"/><xref ref-type="other" rid="par-6"/><xref ref-type="other" rid="par-7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-65961"><name><surname>Procko</surname><given-names>Erik</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-5"/><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-65962"><name><surname>Margineantu</surname><given-names>Daciana</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-65963"><name><surname>Lee</surname><given-names>Erinna F</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-8"/><xref ref-type="other" rid="par-9"/><xref ref-type="other" rid="par-12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-65964"><name><surname>Shen</surname><given-names>Betty W</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-65965"><name><surname>Zelter</surname><given-names>Alex</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-65966"><name><surname>Silva</surname><given-names>Daniel-Adriano</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-10"/><xref ref-type="other" rid="par-11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-65979"><name><surname>Chawla</surname><given-names>Kusum</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-39641"><name><surname>Herold</surname><given-names>Marco J</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-65967"><name><surname>Garnier</surname><given-names>Jean-Marc</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-69357"><name><surname>Johnson</surname><given-names>Richard</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-69358"><name><surname>MacCoss</surname><given-names>Michael J</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-65970"><name><surname>Lessene</surname><given-names>Guillaume</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1193-8147</contrib-id><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-27280"><name><surname>Davis</surname><given-names>Trisha N</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4797-3152</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-65971"><name><surname>Stayton</surname><given-names>Patrick S</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-65972"><name><surname>Stoddard</surname><given-names>Barry L</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-65973"><name><surname>Fairlie</surname><given-names>W Douglas</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-8"/><xref ref-type="other" rid="par-9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-65974"><name><surname>Hockenbery</surname><given-names>David M</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-8806"><name><surname>Baker</surname><given-names>David</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7896-6217</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-5"/><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Bioengineering</institution>, <institution>University of Washington</institution>, <addr-line><named-content content-type="city">Seattle</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Department of Biochemistry</institution>, <institution>University of Washington</institution>, <addr-line><named-content content-type="city">Seattle</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Clinical Research Division</institution>, <institution>Fred Hutchinson Cancer Research Center</institution>, <addr-line><named-content content-type="city">Seattle</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Department of Chemistry and Physics</institution>, <institution>LaTrobe Institute for Molecular Science</institution>, <addr-line><named-content content-type="city">Melbourne</named-content></addr-line>, <country>Australia</country></aff><aff id="aff5"><institution content-type="dept">Basic Sciences Division</institution>, <institution>Fred Hutchinson Cancer Research Center</institution>, <addr-line><named-content content-type="city">Seattle</named-content></addr-line>, <country>United States</country></aff><aff id="aff6"><institution>The Walter and Eliza Hall Institute of Medical Research</institution>, <addr-line><named-content content-type="city">Parkville</named-content></addr-line>, <country>Australia</country></aff><aff id="aff7"><institution content-type="dept">Department of Genome Sciences</institution>, <institution>University of Washington</institution>, <addr-line><named-content content-type="city">Seattle</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-4398"><name><surname>Shan</surname><given-names>Yibing</given-names></name><role>Reviewing editor</role><aff><institution>DE Shaw Research</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>berger389@gmail.com</email> (SB);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>dabaker@uw.edu</email> (DB);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>02</day><month>11</month><year>2016</year></pub-date><volume>5</volume><elocation-id>e20352</elocation-id><history><date date-type="received"><day>04</day><month>08</month><year>2016</year></date><date date-type="accepted"><day>01</day><month>11</month><year>2016</year></date></history><permissions><copyright-statement>© 2016, Berger et al</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Berger et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-20352-v1.pdf"/><abstract><p>Many cancers overexpress one or more of the six human pro-survival BCL2 family proteins to evade apoptosis. To determine which BCL2 protein or proteins block apoptosis in different cancers, we computationally designed three-helix bundle protein inhibitors specific for each BCL2 pro-survival protein. Following <italic>in vitro</italic> optimization, each inhibitor binds its target with high picomolar to low nanomolar affinity and at least 300-fold specificity. Expression of the designed inhibitors in human cancer cell lines revealed unique dependencies on BCL2 proteins for survival which could not be inferred from other BCL2 profiling methods. Our results show that designed inhibitors can be generated for each member of a closely-knit protein family to probe the importance of specific protein-protein interactions in complex biological processes.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>P41GM103533</award-id><principal-award-recipient><name><surname>Berger</surname><given-names>Stephanie</given-names></name><name><surname>Procko</surname><given-names>Erik</given-names></name><name><surname>Baker</surname><given-names>David</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000923</institution-id><institution>Australian Research Council</institution></institution-wrap></funding-source><award-id>FT150100212</award-id><principal-award-recipient><name><surname>Lee</surname><given-names>Erinna F</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01 GM115545</award-id><principal-award-recipient><name><surname>Shen</surname><given-names>Betty W</given-names></name><name><surname>Stoddard</surname><given-names>Barry L</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01 CA158921-04</award-id><principal-award-recipient><name><surname>Margineantu</surname><given-names>Daciana</given-names></name><name><surname>Hockenbery</surname><given-names>David M</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000774</institution-id><institution>Defense Threat Reduction Agency</institution></institution-wrap></funding-source><award-id>HDTRA1-10-0040</award-id><principal-award-recipient><name><surname>Berger</surname><given-names>Stephanie</given-names></name><name><surname>Procko</surname><given-names>Erik</given-names></name><name><surname>Baker</surname><given-names>David</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000011</institution-id><institution>Howard Hughes Medical Institute</institution></institution-wrap></funding-source><award-id>HHMI-027779</award-id><principal-award-recipient><name><surname>Berger</surname><given-names>Stephanie</given-names></name><name><surname>Procko</surname><given-names>Erik</given-names></name><name><surname>Baker</surname><given-names>David</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000001</institution-id><institution>National Science Foundation</institution></institution-wrap></funding-source><award-id>Graduate Research Fellowship Program</award-id><principal-award-recipient><name><surname>Berger</surname><given-names>Stephanie</given-names></name></principal-award-recipient></award-group><award-group id="par-8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100007287</institution-id><institution>Worldwide Cancer Research</institution></institution-wrap></funding-source><award-id>15-0025</award-id><principal-award-recipient><name><surname>Lee</surname><given-names>Erinna F</given-names></name><name><surname>Fairlie</surname><given-names>W Douglas</given-names></name></principal-award-recipient></award-group><award-group id="par-9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000951</institution-id><institution>Cancer Council Victoria</institution></institution-wrap></funding-source><award-id>1057949</award-id><principal-award-recipient><name><surname>Lee</surname><given-names>Erinna F</given-names></name><name><surname>Fairlie</surname><given-names>W Douglas</given-names></name></principal-award-recipient></award-group><award-group id="par-10"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000875</institution-id><institution>Pew Charitable Trusts</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Silva</surname><given-names>Daniel-Adriano</given-names></name></principal-award-recipient></award-group><award-group id="par-11"><funding-source><institution-wrap><institution>Consejo Nacional de Ciencia y Tecnología</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Silva</surname><given-names>Daniel-Adriano</given-names></name></principal-award-recipient></award-group><award-group id="par-12"><funding-source><institution-wrap><institution>National Health and Medical Research Council</institution></institution-wrap></funding-source><award-id>1024620</award-id><principal-award-recipient><name><surname>Lee</surname><given-names>Erinna F</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="datasets"><title>Major datasets</title><p/><p>The following datasets were generated:</p><p><related-object content-type="generated-dataset" id="dataro1" source-id="http://www.nbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE80194" source-id-type="uri"><collab>Berger S</collab>, <collab>Procko E</collab>, <collab>Baker D</collab>, <year>2016</year><x>,</x> <source>Computationally designed, high specificity inhibitors delineate the roles of BCL2 family proteins in cancer</source><x>,</x> <ext-link ext-link-type="uri" xlink:href="http://www.nbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE80194">http://www.nbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE80194</ext-link><x>,</x> <comment>Publicly available at the NCBI Gene Expression Omnibus (accession no: GSE80194)</comment></related-object></p></sec><supplementary-material><ext-link xlink:href="elife-20352-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>